Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis
Wirtz TH, Reuken PA, Jansen C, Fischer P, Bergmann I, Backhaus C, Emontzpohl C, Reißing J, Brandt EF, Koenen MT, Schneider KM, Schierwagen R, Brol MJ, Chang J, Zimmermann HW, Köse-Vogel N, Eggermann T, Kurth I, Stoppe C, Bucala R, Bernhagen J, Praktiknjo M, Stallmach A, Trautwein C, Trebicka J, Bruns T, Berres ML. Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis. JHEP Reports 2020, 3: 100221. PMID: 33659891, PMCID: PMC7890204, DOI: 10.1016/j.jhepr.2020.100221.Peer-Reviewed Original ResearchMacrophage migration inhibitory factorConcentrations of MIFMigration inhibitory factorTransplant-free survivalAcute decompensationInhibitory factorSystemic inflammationReceptor CD74Serum concentrationsHigher macrophage migration inhibitory factorTransjugular intrahepatic portosystemic shunt insertionInflammatory cytokine macrophage migration inhibitory factorCytokine macrophage migration inhibitory factorHigher MIF concentrationsRight atrial bloodWorsening of ascitesChronic liver failureLiver function parametersShort-term mortalityHigher serum levelsMIF promoter polymorphismsRisk of deathPortal venous bloodInnate immune responseClassical scoring systems